Eagle’s Eye View: When DOACS Should Not Be Used as Standard Treatment, Intervention for Complex Coronary Lesions through OCT vs IVUS, Impact of Bempedoic Acid on CV Events
Release Date:
In this week’s View, Dr. Eagle discusses a JACC State of the Art Review noting direct oral anticoagulants (DOACs) should not be standard treatment. He then explores various ways of guiding intervention for complex coronary lesions by optical coherence tomography (OCT) or intravascular ultrasound (IVUS). Finally, Dr. Eagle talks about a prespecified analysis of the CLEAR Outcomes Randomized Trial on the impact of bempedoic acid on total cardiovascular events. Subscribe to Eagle’s Eye View
Eagle’s Eye View: When DOACS Should Not Be Used as Standard Treatment, Intervention for Complex Coronary Lesions through OCT vs IVUS, Impact of Bempedoic Acid on CV Events